These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14403738)

  • 1. Fluoxymesterone ("halotestin"): a new androgen.
    HUDSON B
    Med J Aust; 1959 Oct; 46(2)():468-70. PubMed ID: 14403738
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor efficacy of fluoxymesterone. Use in advanced breast cancer.
    LOWE R; DE LORIMIER AA; GORDAN GS; GOLDMAN L
    Arch Intern Med; 1961 Feb; 107():241-4. PubMed ID: 13763814
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of advanced breast carcinoma with fluoxymesterone. Results of 43 personal cases].
    VERONESI U; DI RE F
    Tumori; 1961; 47():453-61. PubMed ID: 13925546
    [No Abstract]   [Full Text] [Related]  

  • 4. [The combination of ethinylestradiol and fluoxymesterone in the treatment of disorders of the female climacteric].
    BOCCI A; VISCHI F
    Minerva Ginecol; 1961 Sep; 13():871-81. PubMed ID: 13870332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fluoxymesterone, the rebound phenomenon and the biochemistry of human seminal fluid].
    PASETTO N
    Arch Maragliano Patol Clin; 1961 Aug; 17():707-12. PubMed ID: 14484160
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative evaluation of adrenalectomy and androgen in advanced mammary carcinoma.
    DAO TL; TAN E
    Cancer Chemother Rep; 1962 Feb; 16():309-15. PubMed ID: 13883500
    [No Abstract]   [Full Text] [Related]  

  • 7. [New anabolizing androgens in the treatment of painful osteoporoses].
    BORDIER P
    Gaz Med Fr; 1956-1961; (Special)():298-305. PubMed ID: 13871233
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of postmenopausal osteoporosis with oestrogens and androgens.
    HERNBERG CA
    Acta Endocrinol (Copenh); 1960 May; 34():51-9. PubMed ID: 14401286
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgens in advanced cancer of the breast.
    DeCOURCY JL
    Cinci J Med; 1948 Oct; 29(10):556-9. PubMed ID: 18884818
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new method of intraoperative hormone therapy in breast carcinoma].
    KRAUSS H
    Klin Med Osterr Z Wiss Prakt Med; 1962 Jan; 17():49-62. PubMed ID: 14459443
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical results and biological controls of the treatment of osteoporosis with norethandrolone. (35 cases)].
    de SEZE ; BORDIER P
    Sem Hop Ther Paris; 1962 Mar; 38():257-62. PubMed ID: 13911035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone therapy and breast cancer].
    RAVAULT PP; MORNEX R
    J Med Lyon; 1962 Jan; 43():139-48. PubMed ID: 14490624
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of tissue culture for hormone therapy in breast carcinoma].
    KELLNER G; TURCIC G
    Klin Med Osterr Z Wiss Prakt Med; 1962 Feb; 17():83-9. PubMed ID: 14454991
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal therapy in cancer of the breast. XVII. The effect of androsterone on clinical course and hormonal excretion.
    SEGALOFF A; WEETH JB; RONGONE EL; BOWERS CY
    Cancer; 1961; 14():195-8. PubMed ID: 13749675
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of androstan-3, 11, dione-17beta-hydroxy, 17-methyl (compound NSC 19605) in the treatment of advanced breast cancer.
    ANSFIELD FJ; OLSON KB; RASCH O
    Cancer; 1962; 15():330-3. PubMed ID: 13861731
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal therapy in cancer of the breast. 18. Effect of androstanediol dipropionate (5 alpha-androstan-3 alpha, 17 beta-diol dipropionate) therapy on clinical course and hormonal excretion.
    SEGALOFF A; WEETH JB; RONGONE EL; MURISON PJ
    Cancer; 1961; 14():707-10. PubMed ID: 13749677
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer.
    Manni A; Arafah BM; Pearson OH
    Cancer; 1981 Dec; 48(11):2507-9. PubMed ID: 7296499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgen therapy in relapses and metastases from breast cancer].
    GARDINI GF; GHIRELLI G
    Minerva Med; 1949 Apr; 40(20):600-9. PubMed ID: 18151396
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of lactation. Use of a fluoxymesterone-ethinyl estradiol combination.
    BARE WW; CORNFELD E; LIPPO F
    JAMA; 1960 Aug; 173():1814-7. PubMed ID: 13796711
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoxymesterone (halotestin) in advanced breast carcinoma.
    STOLL BA
    Med J Aust; 1959 Jan; 46(3):70-4. PubMed ID: 13621861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.